Real-world incidence and clinical characteristics of intraocular inflammation following intravitreal faricimab therapy: A safety study

Macular Diseases

First-year real-world outcomes of faricimab in clinically significant diabetic macular oedema: a Swiss retina research network report

BMJ Open Ophthalmol

Saad A, Plasencia C, Garweg J, Pfister IB, Munk MR, Eandi CM, Zweifel SA, Grimaldi G, Bartolomeo N, Stillenmunkes R, Schild C, Cattaneo J, Gabathuler F, Menghini M, Ambersin A, Froehlich J, Artemiev D, Weinberger A, Mohamed H, Somfai GM, Hatz K

doi: 10.1136/bmjophth-2025-002467

Macular Diseases

Peripapillary Retinal Nerve Fibre and Ganglion Cell Layer Changes Following Intravitreal Aflibercept 8 mg Therapy in Neovascular Age-Related Macular Degeneration: A Longitudinal OCT Study

Ophthalmol Ther

Volpe G, Bonanata M, Peyla A, Ruscitti L, Eggarter V, Pache M, Paris A, Menghini M, Grimaldi G

doi: 10.1007/s40123-026-01431-z

Retinal Diseases

Intravitreal Therapy in Adults Aged ≤50 Years: Etiologic Spectrum, Treatment Patterns and Visual Outcomes in a Real-World Cohort

J Clin Med

Rodríguez-Fernández CA, Oliver-Gutierrez D, Arnaiz A, Pablos T, Segura-Duch G, Zapata MÁ

doi: 10.3390/jcm15124508

Macular Diseases

Real-world early outcomes of intravitreal faricimab 6-mg and aflibercept 2-mg injection in diabetic macular oedema

Br J Ophthalmol

Chalkiadaki E, Sim YS, Williams O, Elder L, Addison PK, Hamilton RD, Nicholson L, Sivaprasad S, Heng LZ

doi: 10.1136/bjo-2025-328893

Glaucoma and Ocular PressureUveitis

Real-World Incidence and Management of Ocular Hypertension Following Suprachoroidal Triamcinolone Acetonide Injection for Macular Edema in Noninfectious Uveitis

Retina

Hamdan SA, Zafar S, Nassur JA, Yonekawa Y, Kuriyan AE, Dunn JP, Cohen MN, Hsu J, Regillo CD, Garg SJ, Xu D, Klufas M, Deaner JD

doi: 10.1097/IAE.0000000000004677

Blindness and Vision ImpairmentSurgery and Intervention

From Surgical Salvage to Blindness Prevention: A Real-World Study of Intraocular Surgery in Monocular Patients

J Clin Med

Guo H, Wei L, Cheng G, Chen Y, Dai R, Zhang Z, Zhang S, Han X, Zhao X, Wang Z, Yu W

doi: 10.3390/jcm15114041

Retinal Diseases

Real-world effect of vitrectomy combined with intravitreal conbercept for treatment of vitreous haemorrhage in proliferative diabetic retinopathy (QILIN I): a prospective cohort study

Br J Ophthalmol

Liu Y, Huang J, Ao M, Huang Y, Ma X, Han Q, Sun D, Zhong J, Qiu Q, Peng H, Wang Z, Ye J, Ma Z, Hao Y, Hu Y, Chang Q, Lu H, Li X, Liang J, Li S, Li J, Yu X, Yang L, Bi C, Li B, Zhang F, Wu R, Jin X, Zhou G, Liao M, Lei Y, Han H, Yan H

doi: 10.1136/bjo-2025-329066

LensesMacular Diseases

Safety and efficacy of an extended macular vision intraocular lens (IOL) for age-related macular degeneration (AMD) in real-world settings

BMC Ophthalmol

Hengerer FH, Stanzel B, Hoyos-Chacon J, Suarez M, Beckers S, Busatto P, Badalà F

doi: 10.1186/s12886-025-04515-9

Macular Diseases

Faricimab in Treatment-Naïve nAMD: Regional UK Real-World Experience

Adv Ther

Pearce I, Dinah C, Downey L, Patwardhan A, Vardarinos A, Williams G

doi: 10.1007/s12325-026-03534-2

Related content

First-year real-world outcomes of faricimab in clinically significant diabetic macular oedema: a Swiss retina research network report

Peripapillary Retinal Nerve Fibre and Ganglion Cell Layer Changes Following Intravitreal Aflibercept 8 mg Therapy in Neovascular Age-Related Macular Degeneration: A Longitudinal OCT Study

Intravitreal Therapy in Adults Aged ≤50 Years: Etiologic Spectrum, Treatment Patterns and Visual Outcomes in a Real-World Cohort

Real-world early outcomes of intravitreal faricimab 6-mg and aflibercept 2-mg injection in diabetic macular oedema

Real-World Incidence and Management of Ocular Hypertension Following Suprachoroidal Triamcinolone Acetonide Injection for Macular Edema in Noninfectious Uveitis

From Surgical Salvage to Blindness Prevention: A Real-World Study of Intraocular Surgery in Monocular Patients

Real-world effect of vitrectomy combined with intravitreal conbercept for treatment of vitreous haemorrhage in proliferative diabetic retinopathy (QILIN I): a prospective cohort study

Safety and efficacy of an extended macular vision intraocular lens (IOL) for age-related macular degeneration (AMD) in real-world settings

Faricimab in Treatment-Naïve nAMD: Regional UK Real-World Experience